Therefore, the urgent need for treatment of HER2-positive breast cancer is to develop novel drugs or therapies to degrade the overexpressed HER2 in cancer cells, thereby reversing HER2-mediated excessive proliferation and metastasis in several cancers. Here, ERBB2 is linked to breast cancer.